09 December 2020
The REDI program is providing grants of up to $250,000 to industry to secure one of up to 40 industry Fellowships in the medical technology, biotechnology and pharmaceutical (MTP) sector.
This unique workforce initiative is giving industry the opportunity to select a researcher, academic, clinician or technology transfer professional to collaborate on distinct projects involving discovery, translation and commercialisation.
REDI is calling for Australian industry organisations, including multinationals and ASX-listed companies, to apply for a Fellowship, with funding available for up to 40 places.
“Creating links between industry and research is critical for the growth and success of the MTP sector. Our new REDI Fellowships program provides companies with the financial support to bring academics and clinicians in-house for up to twelve months to work on priority medical research projects,” said MTPConnect Managing Director and CEO Dr Dan Grant.
“Our Fellowship program will require that the researcher or clinician return to their home institution for a period at least equal to the term of the fellowship.
“This will help address the issue of ‘brain drain’ of researcher talent into companies and ensure we embed high-level commercial experience in the research sector,” Dr Grant said.
The Fellowship application process is industry-led, so an eligible industry sponsor (company/organisation) needs to submit an application which identifies a Fellow and matches it with a specific research and development project.
Eligible Fellows are medical technology, biotechnology and pharmaceutical sector researchers, academics, clinicians and professionals (technology transfer organisation professionals, entrepreneurs, business development/commercialisation staff, administrators and executives) from academic/public research organisations/hospitals/technology transfer organisations.
Eligible Sponsors are industry organisations defined as a research-intensive organisation such as biotechnology, pharmaceutical, medical device and digital health companies, specialised best practice organisations such as a Venture Capital (VC) firm, regulatory affairs consultancy, medical affairs consultancy, etc. For clarity, universities, medical research institutes and hospitals are not eligible Sponsors for this program.
Sponsors can select three types of Fellowships to apply for:
- One-year full time
- 6 - 12 months full time
- 6 – 12 months where the fellow spends 50% of time working with the sponsor.
Subject to COVID-19 restrictions, domestic and international Fellowships will be considered.
Applications open on 15 December 2020 and will remain open until either the funds are fully committed or until October 2022, whichever is first.